IL1B and adult-onset Still disease: After showing its paramount efficacy in the cryopyrin-associated periodic syndrome, a rare IL-1-mediated hereditary autoinflammatory disorder (Cantarini et al., 2011; Rigante, 2018), ANA started to be employed also in AOSD and sJIA.